CORRECTION: Kindeva(R) commemorates 70 years of the pMDI as inventors are inducted into the 'National Inventors Hall of Fame'

Kindeva/ In the news release, Kindeva(R) commemorates 70 years of the pMDI as inventors are inducted into the 'National Inventors Hall of Fame', issued 23-Mar-2026 by Kindeva over PR Newswire, we are ...
health.economictimes.indiatimes

Lupin launches Luforbec 100/6 for adult asthma, COPD treatment in Germany

Luforbec 100µg/6µg pMDI is indicated for adult asthma and COPD treatment, where the use of an inhaled corticosteroid and long-acting beta2-agonist (ICS/LABA) is suitable. With the same active ...
Nasdaq

Verona Pharma Reports Positive Efficacy and Safety Data with Single Dose pMDI Formulation of Ensifentrine in COPD

LONDON, March 30, 2020 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM: VRP) (Nasdaq: VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on respiratory diseases, announces positive ...
FierceBiotech

AstraZeneca to discontinue production of PULMICORT® pMDI, other respiratory medicines not affected

AstraZeneca will discontinue the production of PULMICORT® (budesonide) 100 and 200 µg/dose HFA pMDI (pressurised metered dose inhaler) due to complex manufacturing issues related to technical aspects ...
Nasdaq

Verona Pharma to Present Phase 2 Data with pMDI Ensifentrine in COPD at CHEST 2021

LONDON and RALEIGH, N.C., Oct. 13, 2021 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on respiratory diseases, announces ...